I spent some time last week wading through literature on the first transgenic (GMO) animal going through the FDA approval process. It’s Aqua Bounty’s AquAdvantage Salmon. The AquAdvantage is a ...

Monsanto was at the center of the GMO debate, developing seeds engineered to resist pests and tolerate herbicides. Supporters saw this as progress, but critics argued it gave the company dangerous ...

GMO Financial Holdings (TSE:7177) delivered earnings growth of 119.6% over the past year, rebounding from a five-year average annual decline of 5.2%. Net profit margins more than doubled to 22.2%, up ...

In the end, industry keeps the savings, while shoppers see none. This is precisely how we became trapped in the endless GMO debate. Two decades ago, regulators and companies made the same mistake: ...